NEWS

On the 40th anniversary of the European Society of Intensive Care Medicine - ESICM, we were very pleased to participate in the Lives 40 congress which took place from 12 to 14 May 2022 in Madrid.

EMOSIS, had the opportunity to present a machine learning predictive model of the diagnosis of heparin-induced thrombocytopenia (HIT).

HIT is a potentially lethal issue that may require intensive care and the model demonstrates the potential of artificial intelligence in “augmenting” the diagnosis of HIT based on flow cytometry.

Thank you to the people who showed interest in our work, and congratulations again to ESICM for honoring health professionals from all over the world!

March 8 is International Women's Rights Day. On this occasion, we felt it was important to point out that there are 11 women at EMOSIS, representing more than 70% of the workforce. Present in R&D, Human Resources, Finance and Administration, Quality, Communication and Regulatory Affairs, we wanted to honor them!

From 1 to 4 March 2022, EMOSIS was present at the GTH Congress in Leipzig, Germany!

On March 2, during the session dedicated to laboratory diagnostics, we had the pleasure to present our poster "Does my patient have a HIT? There should be an app for that." This was the first oral communication around our NomoHIT application.

On the occasion of the 12th edition of the SME Trophies, the RMC team made a report on EMOSIS.

Today, we invite you to discover the backstage of our company: https://lnkd.in/eTkmZ3uR

This 13th of January EMOSIS celebrates its 7th anniversary! To celebrate this additional anniversary, we invite you to discover our retrospective of this last year.

What happened in 2021? Follow the link:
https://www.linkedin.com/feed/update/urn:li:activity:6887407357375123457